Table 1 Baseline Characteristics of Patients (n = 160)
Characteristic | Control cohort (n = 81) | Intervention cohort (n = 79) | P-Value |
|---|---|---|---|
Age in years, mean (±SD) | 83.2 (±5.1) | 83.8 (±5.6) | 0.486a |
Female, n (%) | 34 (42.0%) | 51 (64.6) | 0.005b |
Social living circumstances, n (%) | Â | Â | 0.359b |
 At home, alone | 30 (37.1) | 32 (40.5) |  |
 At home, with others | 31 (38.3) | 30 (38.0) |  |
 Nursing home/service flat | 18 (22.2) | 16 (20.2) |  |
 Other | 2 (2.4) | 1 (1.3) |  |
Main diagnosis, n (%) | Â | Â | 0.531b |
 Heart failure and respiratory insufficiency | 10 (12.4) | 15 (19.0) |  |
 Infectious disease | 25 (30.9) | 22 (27.9) |  |
 Gastro-intestinal disease | 14 (17.3) | 10 (12.7) |  |
 Falls-fractures-osteoporosis | 21 (25.9) | 15 (19.0) |  |
 Neuropsychiatric disease | 5 (6.2) | 5 (6.3) |  |
 Cancer | 2 (2.5) | 6 (7.6) |  |
 Other | 4 (4.9) | 6 (7.6) |  |
Number of comorbidities, mean (±SD) | 2.7 (±1.5) | 2.5 (±1.6) | 0.365c |
Number of medication, mean (±SD) | 3.5 (±8.0) | 3.2 (±8.0) | 0.839a |
Premorbid Katz ADL score, mean (±SD) (range 0–12) | 2.9 (±3.0) | 4.4 (±3.5) | 0.004c |
Baseline Mini-Mental State Examination score, mean (±SD) (range 0–12) | 8.4 (±3.4) | 8.0 (±3.5) | 0.509a |
Dementia, n (%) | 16 (19.8) | 11 (13.9) | 0.400b |
History of delirium, n (%) | 13 (16.1) | 12 (15.4) | 1.000b |